I am currently testing certain compounds' effects on neutrophil activation and ROS generation (i.e. luminol-based chemiluminescence) is one of my readouts. Both PMA and LPS are included as positive controls. However, donor-dependent variable response to LPS has been observed. Is there a way for me to minimise or eliminate this problem?
Separately, my compound-of-interest reduced ROS generation by neutrophils when compared to no treatment control (spontaneous ROS observed). It has been reproduced several times regardless of response to LPS. Is there a good biological negative control I could use to verify this, instead of DPI or TEMPOL?